Effect of mizoribine in children with inflammatory bowel disease
โ Scribed by Tohru Fujii; Yoshikazu Ohtsuka; Yoko Yamakawa; Kiyotaka Ohtani; Takahiro Kudo; Yoshiyuki Ohtomo; Satoru Nagata; Toshiaki Shimizu
- Book ID
- 108972878
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 51 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1328-8067
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The causes of exacerbations of inflammatory bowel disease (IBD) are unknown. The presence of RNA of an enterovirus, norovirus GI, norovirus GII, rotavirus, astrovirus, and sapovirus was sought in stool samples of 50 children (median age 12.9 years) undergoing gastrointestinal endoscopie
A lO-year-old child with ulcerative colitis is described who during the quiescent phase of his disease suffered from pericarditis with pleuropericardial effusion. The literature on cardiac involvement in inflammatory bowel disease is reviewed with emphasis on the paediatric age group.
About 30% of individuals with inflammatory bowel disease present before the age of 21 years (1). Despite this prevalence, most therapeutic agents are tested in adults with inflammatory bowel disease and pharmacokinetics, safety, and efficacy may never be studied in children and adolescents. In this